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It is a honour and a privilege for me, on behalf of the 
European Cystic Fibrosis Society, to host the European 
Cystic Fibrosis Conference, which is held for the first time 
in Genoa, and returns to Italy after 28 years. 
With this year’s Conference, the ECFS celebrates a 
quarter of a century of intense and fruitful activity. Far 
from being redundant, the 25th European CF Conference 
witnesses the lively and enterprising spirit of the ECFS.
This year, the “Ettore Rossi” medal of the European 
CF Society is awarded for the first time. The award, 
named after and in honour of the founder of the European 
Working Group for CF which was to become the ECFS, 
will be an annual tribute to people who made a significant 
contribution to our understanding of CF or to the treatment 
or care of patients.
This year, a great effort was made in the Conference 
organisation in order to dedicate more space to discuss 
basic science research. ECFS endeavor was successful: 
for the first time, the scientific content of the European 
Conference is rather equally divided between basic science 
and clinical issues.
This year, participation of young researchers submitting 
their work was particularly encouraged and facilitated, in 
the hope of promoting and fostering the future development 
of research on CF.
This year, the ECFS proved its vitality by launching 
a new journal, the Journal of Cystic Fibrosis, and I am 
particularly proud that the abstracts accepted for the 
25th European CF Conference are published on the first 
supplement of the Journal of CF.
A most promising scientific programme awaits the 
attendees of the 25th European CF Conference, with 24 
up-to-date and interesting major sessions, and over 100 free 
oral communications, selected out of 370 submitted papers, 
all reflecting the broad spectrum of interests drawn by CF, 
and, at the same time, the aim of the ECFS to bring together 
basic and clinical research. 
Communication among scientists is of the outmost 
importance for scientific progress. The Conference 
represents the best forum where basic science and clinical 
research new data are presented and discussed among 
fellow researchers from different Institutions and Countries. 
It is my duty to thank all participants to the Conference, 
because it is with their contribution that the Conference will 
accelerate progression towards a cure for CF.
The Conference also represents the opportunity for 
delegates to get acquainted personally and to deepen the 
mutual understanding of each other.
I do hope that all participants to the Conference will 
be stimulated and inspired by the scientific sessions, and 
in addition will be able to relax, enjoy the city and its 
environment. 
Benvenuti a Genova,
Luca Romano
25th ECFC Chairman
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